HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization.

Abstract
In this study, we show that recombinant human histidine-rich glycoprotein (HRGP) has potent antiangiogenic properties as judged from effects on a syngeneic tumor model in C57/bl6 mice. Growth of fibrosarcoma, a very aggressive tumor, was reduced by >60% by HRGP treatment, and tumor angiogenesis was dramatically decreased. Treatment with HRGP led to increased apoptosis and reduced proliferation in the tumors. In contrast, HRGP did not affect apoptosis or DNA synthesis in endothelial cells or tumor cells in vitro. The mechanism of action of HRGP involves rearrangement of focal adhesions and decreased attachment of endothelial cells to vitronectin and, as a consequence, reduced endothelial cell migration. By using truncated versions of HRGP, we demonstrate that the isolated 150 amino acid-residue His/Pro-rich domain, which is also released by spontaneous proteolysis from purified HRGP, mediates the inhibitory effect on chemotaxis. Moreover, the His/Pro-rich domain must be released from HRGP to exert its effect. This study shows for the first time inhibitory effects of HRGP on tumor vascularization in vivo, thus providing proof of concept that HRGP is an angiogenesis inhibitor.
AuthorsAnna-Karin Olsson, Helena Larsson, Johan Dixelius, Irja Johansson, Chunsik Lee, Cornelia Oellig, Ingemar Björk, Lena Claesson-Welsh
JournalCancer research (Cancer Res) Vol. 64 Issue 2 Pg. 599-605 (Jan 15 2004) ISSN: 0008-5472 [Print] United States
PMID14744774 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Peptide Fragments
  • Proteins
  • Recombinant Proteins
  • histidine-rich proteins
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Aorta
  • Bone Neoplasms (blood supply, drug therapy)
  • Cell Adhesion (drug effects)
  • Disease Models, Animal
  • Endothelium, Vascular (drug effects, physiology)
  • Fibrosarcoma (blood supply, drug therapy)
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms (blood supply)
  • Neovascularization, Pathologic (prevention & control)
  • Peptide Fragments (pharmacology)
  • Proteins (chemistry, pharmacology)
  • Recombinant Proteins (pharmacology)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: